Breast Cancer Patients Benefit From Continued Use of Herceptin After Progression
Data presented at the 30th Annual San Antonio Breast Cancer Symposium confirm that Herceptin is the standard of care for women with HER2-positive breast cancer across all stages of the disease
Full article: http://www.presseportal.de/pm/24678/...harmaceuticals |
All times are GMT -7. The time now is 07:57 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021